The 2019 Genitourinary Pathology Society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of pathology & …, 2021 - meridian.allenpress.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

[HTML][HTML] The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

JI Epstein, MB Amin, SW Fine, F Algaba… - Archives of pathology …, 2020 - folia.unifr.ch
Percent Gleason pattern 4 (% GP4) is as follows:(1) report% GP4 in needle biopsy with
Grade Groups (GrGp) 2 and 3, and in needle biopsy on other parts (jars) of lower grade in …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of Pathology and …, 2021 - ohiostate.elsevierpure.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

JI Epstein, MB Amin, SW Fine… - … of Pathology & …, 2021 - search.ebscohost.com
Context.--Controversies and uncertainty persist in prostate cancer grading. Objective.--To
update grading recommendations. Data Sources.--Critical review of the literature along with …

The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer.

JI Epstein, MB Amin, SW Fine, F Algaba… - Archives of pathology …, 2021 - boris.unibe.ch
CONTEXT.—Controversies and uncertainty persist in prostate cancer grading. OBJECTIVE.—
To update grading recommendations. DATA SOURCES.—Critical review of the literature …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of Pathology and …, 2021 - ohsu.elsevierpure.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - Archives of …, 2021 - utsouthwestern.elsevierpure.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of Pathology and …, 2021 - pure.johnshopkins.edu
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine, F Algaba… - … OF PATHOLOGY & …, 2021 - iris.unisr.it
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …

The 2019 genitourinary pathology society (GUPS) white paper on contemporary grading of prostate cancer

JI Epstein, MB Amin, SW Fine… - … of Pathology and …, 2021 - mayoclinic.elsevierpure.com
Context.—Controversies and uncertainty persist in prostate cancer grading. Objective.—To
update grading recommendations. Data Sources.—Critical review of the literature along with …